AICPI
ABG Innovation Capital Partners III Portfolio holdings
AUM
$49.9K
This Quarter Return
+60.05%
1 Year Return
+0.25%
3 Year Return
-18.22%
5 Year Return
–
10 Year Return
–
AUM
$170M
AUM Growth
–
Cap. Flow
+$170M
Cap. Flow
% of AUM
100%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
7
New
7
Increased
–
Reduced
–
Closed
–
Top Buys
| 1 |
Atea Pharmaceuticals
AVIR
|
$110M |
| 2 |
Pulmonx
LUNG
|
$57.5M |
| 3 |
GNCA
Genocea Biosciences, Inc.
GNCA
|
$908K |
| 4 |
Synlogic
SYBX
|
$445K |
| 5 |
WHWK
Whitehawk Therapeutics, Inc. Common Stock
WHWK
|
$392K |
Top Sells
No sells this quarter
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Atea Pharmaceuticals
AVIR
$267M
| $110M | 64.92% | +2,639,178 | New | +$110M |
|
|
2
Pulmonx
LUNG
$69.7M
| $57.5M | 33.86% | +833,333 | New | +$57.5M |
|
|
GNCA
3
DELISTED
Genocea Biosciences, Inc.
GNCA
| $908K | 0.53% | +375,000 | New | +$908K |
|
|
4
Synlogic
SYBX
$17M
| $445K | 0.26% | +205,906 | New | +$445K |
|
|
WHWK
5
Whitehawk Therapeutics, Inc. Common Stock
WHWK
$85.1M
| $392K | 0.23% | +400,000 | New | +$392K |
|
|
ACGN
6
DELISTED
Aceragen, Inc. Common Stock
ACGN
| $206K | 0.12% | +56,250 | New | +$206K |
|
|
NBRV
7
DELISTED
Nabriva Therapeutics plc Ordinary Shares Ireland
NBRV
| $111K | 0.07% | +45,849 | New | +$111K |
|